OLATHE, Kan., Jan. 11, 2018 -- Hooper Holmes, Inc. (OTCQX:HPHW), the nation’s largest publicly-traded pure-play health and well-being solutions provider, announced today that Marc Salois has been named chief revenue officer. Salois is a highly experienced sales executive with a history of building cultures of sales and expanding into new markets. In his most recent role, Salois’ team achieved double-digit growth for three consecutive years.
"Marc brings an outstanding track record of business development to Hooper Holmes. He has strong knowledge of the industry, expertise in building successful sales teams, and proven ability to increase revenue,” said Henry Dubois, CEO of Hooper Holmes.
“This has been an exciting year for Hooper Holmes, as we have seen our organization continue to evolve. Marc brings a wealth of executive experience to our team, and will be an important strategic voice. We look forward to his insight and leadership,” said President Mark Clermont.
Salois brings more than 15 years of sales leadership experience to the company. Most recently, he was vice president of Enterprise Sales, East, at Omada Health, where he was responsible for sales, implementation, and account management teams in the Eastern US. Omada is a digital health company whose mission is to enable people to live free of chronic disease. Prior to that, Salois was vice president of sales at meQuilibrium, vice president of sales at HighRoads, and is currently an advisor at Harvard Innovation Labs.
“Joining Hooper Holmes at this point in its growth is a tremendous opportunity. The company has strong customer loyalty, high participant satisfaction, and a large and growing list of customers who are industry leaders across North America,” said Salois. “Hooper Holmes is in an excellent position in an expanding market. I am delighted to join such a well-respected company that has great customers, best-of-breed partners, a first-class leadership team, and employees who are truly committed to helping people be their best selves.”
Salois has a Bachelor of Science degree in Medical Technology from the University of Massachusetts.
About Hooper Holmes
Hooper Holmes, Inc. is a leader in workplace wellness and clinical research support services. The company mobilizes a national network of health professionals to provide on-site health screenings, laboratory testing, risk assessment and sample collection services to wellness and disease management companies, employers and brokers, government organizations and academic institutions nationwide. Provant, a wholly-owned subsidiary of Hooper Holmes, Inc., is a leader in comprehensive workplace well-being solutions with a growing, global presence. Provant partners with employers and brokers to improve member health and productivity and support healthcare cost management. Provant touches millions of lives by delivering customized well-being strategies and services on-site, telephonically and digitally, utilizing advanced data management technology.
For further information:
Hooper Holmes/Provant
Elaine Peterson
Senior Director, Marketing & Communications
(401) 234-0165


SpaceX Pushes for Early Stock Index Inclusion Ahead of Potential Record-Breaking IPO
Ford and Geely Explore Strategic Manufacturing Partnership in Europe
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Alphabet’s Massive AI Spending Surge Signals Confidence in Google’s Growth Engine
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Weight-Loss Drug Ads Take Over the Super Bowl as Pharma Embraces Direct-to-Consumer Marketing
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
TSMC Eyes 3nm Chip Production in Japan with $17 Billion Kumamoto Investment
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil 



